HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

K Tamaki Selected Research

U3 small nucleolar ribonucleoprotein

11/2001Prevalence in myositis of antibodies recognizing anti-U3 RNA probably in a novel complex with 22/25 kD protein and not fibrillarin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


K Tamaki Research Topics

Disease

12Systemic Scleroderma (Systemic Sclerosis)
03/2006 - 01/2000
11Atopic Dermatitis (Atopic Eczema)
09/2007 - 05/2000
8Fibrosis (Cirrhosis)
05/2006 - 01/2000
7Psoriasis (Pustulosis Palmaris et Plantaris)
11/2008 - 06/2000
7Pulmonary Fibrosis (Hamman Rich Syndrome)
03/2006 - 01/2000
6Neoplasms (Cancer)
09/2006 - 01/2000
6Localized Scleroderma (Morphea)
07/2006 - 01/2000
6Mixed Connective Tissue Disease (MCTD)
07/2005 - 09/2001
4Dermatomyositis (Dermatopolymyositis)
11/2002 - 06/2000
4Inflammation
06/2002 - 07/2000
3Cicatrix (Scar)
10/2009 - 11/2000
3Stroke (Strokes)
05/2008 - 08/2000
3Bullous Pemphigoid (Pemphigoid)
01/2007 - 07/2000
3Skin Diseases
06/2006 - 01/2001
3Sclerosis
05/2006 - 01/2000
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
06/2010 - 06/2009
2Melanoma (Melanoma, Malignant)
11/2008 - 10/2001
2Brain Infarction
05/2008 - 10/2007
2Alopecia Areata
09/2007 - 01/2002
2Diffuse Scleroderma (Progressive Systemic Sclerosis)
05/2007 - 06/2005
2Autoimmune Diseases (Autoimmune Disease)
01/2007 - 09/2001
2Contracture
10/2004 - 11/2001
2Collagen Diseases (Collagen Disease)
10/2004 - 04/2003
2Fasciitis (Fascitis)
08/2004 - 02/2003
2Graft vs Host Disease (Graft-Versus-Host Disease)
10/2003 - 04/2003
2Blister (Bulla)
02/2003 - 07/2000
2Eosinophilia
02/2003 - 07/2000
2Interstitial Lung Diseases (Interstitial Lung Disease)
11/2002 - 06/2000
2Hepatocellular Carcinoma (Hepatoma)
01/2002 - 06/2001
2Glomerulonephritis
12/2001 - 02/2001
2Breast Neoplasms (Breast Cancer)
11/2001 - 01/2000
2Infection
10/2001 - 12/2000
2Neoplasm Metastasis (Metastasis)
06/2001 - 11/2000
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2000 - 01/2000
2Hypertension (High Blood Pressure)
08/2000 - 04/2000
1Telangiectasis (Telangiectasia)
10/2009
1Calcinosis
10/2009
1Insulin Resistance
05/2008
1Cardiovascular Diseases (Cardiovascular Disease)
10/2007
1Fanconi Syndrome (Syndrome, Fanconi)
04/2007
1Pemphigus (Pemphigus Vulgaris)
03/2007
1Vitiligo
01/2007
1Necrosis
08/2006

Drug/Important Bio-Agent (IBA)

7AntibodiesIBA
04/2005 - 01/2000
6Transforming Growth Factor beta (TGF-beta)IBA
05/2006 - 01/2000
5AntigensIBA
08/2006 - 12/2000
4Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
05/2006 - 02/2001
4Tissue Inhibitor of Metalloproteinase-1IBA
08/2004 - 10/2001
3Carbon MonoxideIBA
10/2009 - 06/2000
3Biological Markers (Surrogate Marker)IBA
11/2008 - 04/2000
3Chemokine CCL5IBA
09/2007 - 01/2001
3ChemokinesIBA
09/2007 - 08/2001
3CD40 Ligand (CD40L)IBA
01/2007 - 02/2003
3Rheumatoid FactorIBA
07/2005 - 01/2003
3Immunoglobulin E (IgE)IBA
01/2005 - 02/2001
3Immunoglobulin A (IgA)IBA
10/2004 - 01/2001
3Tissue Inhibitor of Metalloproteinases (TIMP)IBA
08/2004 - 01/2000
3Tissue Inhibitor of Metalloproteinase-2IBA
07/2002 - 01/2000
3RNA (Ribonucleic Acid)IBA
05/2002 - 06/2001
2Chemokine CCL4IBA
09/2007 - 03/2007
2InterferonsIBA
09/2007 - 03/2007
2Matrix Metalloproteinase 13IBA
07/2006 - 03/2006
2Interleukin-12 (IL 12)IBA
06/2006 - 05/2000
2InterleukinsIBA
06/2006 - 07/2000
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2006 - 05/2000
2Itraconazole (Sporanox)FDA LinkGeneric
09/2005 - 06/2003
2Immunoglobulin M (IgM)IBA
07/2005 - 10/2004
2agalactosyl IGGIBA
04/2005 - 10/2004
2Immunoglobulin G (IgG)IBA
10/2004 - 11/2000
2AD 20 (AD-20)IBA
11/2003 - 03/2001
2Chemokine CCL17IBA
02/2003 - 03/2001
2Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
11/2002 - 06/2001
2Transforming Growth Factor beta1 (TGF beta 1)IBA
12/2001 - 04/2000
2TinIBA
11/2001 - 01/2000
2Colloids (Colloid)IBA
11/2001 - 01/2000
2RibonucleoproteinsIBA
09/2001 - 06/2001
2E-SelectinIBA
08/2000 - 01/2000
2Nitric Oxide Synthase (NO Synthase)IBA
08/2000 - 04/2000
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2000 - 01/2000
1Interleukin-17 (Interleukin 27)IBA
06/2010
1thymic stromal lymphopoietinIBA
06/2009
1Melanins (Melanin)IBA
11/2008
1PsoralensIBA
11/2008
1CysteinyldopaIBA
11/2008
1pheomelaninIBA
11/2008
1Insulin (Novolin)FDA Link
05/2008
1sorbinIBA
05/2008
1Fluorescent Dyes (Fluorescent Probes)IBA
05/2008
1NADPH Oxidase (NAD(P)H oxidase)IBA
10/2007
1Interleukin-8 (Interleukin 8)IBA
09/2007
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2007
1Immunoglobulins (Immunoglobulin)IBA
05/2007
1Tubulointerstitial nephritis and uveitisIBA
04/2007
1BP 16IBA
03/2007
1Uric Acid (Urate)IBA
01/2007
1B-Cell Activating FactorIBA
08/2006

Therapy/Procedure

2Phototherapy (Light Therapy)
11/2008 - 01/2007
2Drug Therapy (Chemotherapy)
09/2006 - 02/2000
2Transplantation (Transplant Recipients)
10/2003 - 04/2003
2Aftercare (After-Treatment)
12/2001 - 02/2000